Look at what happened to suich industries today. Please stay away from any company sme which comes either with high p/e or bad business model. Suich is bad business and Sudarshan is very high pe. It is shame to come with 40 + pe for such large issue
ye IPO main Price is agrresiv...very costly...but company promoters are good... fundamental acche hai...some time agressive price shows promoters confidence... Medicine Bana to leti hai ye company...nahi to Suich kuch products nahi hai Suich ke...our aye hai market se 30cr Lene...
About products, they have 4 first time in India products, 2 patented products, their product love bird is excellent and first time kind of in India, their medicine called "setdown" is excellent one you could get the information on google too., for samples of lovebird you could contact company, i collected few samples it was excellent...
I don't think so that employee or relative invest such a big amount., i feel it is useless to block 1.2 lakh for 5 days and suspending the application on the last day in country like India. Its a real investments
There is an interesting data, Below the data shows relevantly successful SME IPO's for the past 3 months.
IPO Name - Listing Gain - Till date Gain - RII Subscription - NII Subscription - Total Subscription - LM Name =================================================================================== Artemis Electricals 16.42% 61.67% 0.45 1.67 1.06 Fedex Securities Evans Electric Ltd 5.38% 159.62% 0.56 2.63 1.59 Hem Securities White Organic Retail 2.06% 31.83% 0.70 2.02 1.36 Finshore Management GKP Printing & Packaging 9.38% 43.75% 1.56 1.57 1.56 Holani Consultants Osia Hyper 6.19% 12.7% 0.57 1.66 1.12 Monarch Networth
Interesting facts from the above data,
1. Total subscription figure for all these IPO's less than 2x. 2. 4 out of 5 IPO's not fully subscribed under RII quota. 3. 4 out of 5 IPO's listing gain was less than 10% 4. Last but not least, none of these IPO's LM was Pantomath Capital
These facts shows, whatever we believe are totally wrong. Are we most of the investors travelling in opposite direction?
I am not an expert, but these data and facts confusing me.
I always believed IPO performance has nothing to do with lead manager. Success depends on company fundamentals, trust among investor and good pricing. I do not like the fancy that some folks in this forum have created for Pantomath.
Dear Prabahar Applying sme stock , allotment and positive listing are pure LUCK. Your mentioned stock some of our board members applied and might got good profit. For example Gkp Small investor applied and exited on listing day. Dear Sir I applied lot of sme before Artemis Evans period of time . but no one gave substantial profit. For example Anmol Mindpool, Kranti,Glem, Artech Solanics Northern Spirit all arer listed at par or below issue price. So vexed with sme stocks and i didnt apply your mentioned stocks. Sir, No one predicts at the time opening of issues whether that stock perform well or not. SME STOCKS IS PURE LUCK. IF YOU APPLIED and exited and at correct level you are the luckiest person.
Dear Rajakumar, yes i agree with you. It's all pure based on luck. But same time, why we are unable to predict it. 3 fails out of 10 predictions are acceptable. But if 7-8 fails, then we need to do some other way for prediction. Also we have to admit, most of the time in past one year, the market is not stable.
Yes you are right. But same time, if the company is good, LM's can boost it. Some time due to LM and Operators, some worst company also comes with listing gain. But they cant sustain for long run. But thats not matter for listing gain.
Dear Prabahar I accept you views. LM is not only parameter for good listing. Some other parameters are there. Pantamoth cannot list all the shares with decent premium. Pantamoth lot of time fails to stabilise the issue price after 10 am. For one sme stock LM alone cannot list with premium and stabilising the price, there must be some operators are involved. We cannot find at the time of issue opening.
it is good company, read its IPO review in few of the papers, they work ethically and have cliental in phamacy and chemical market, we should opt for long term investment in this company.
Eps as on 30.9.18 is 1.82 translates into full year it comes 3.6 Eps as on 31.3.18 is 2.9 Pe 25 times as on 2018 (pe is high to its peers) Pe as on 31.3.19 is 20 RONW 14.5 NAV after the issue is 34. So book value is 2.3 times Alembic trading at 24 pe shilpa medi 29 pe TTK HEALTH 36 pe Biocon 57 pe Torrent Pharma 38 pe (DRHP page 93) Short term debt 6 cr. Long term debt 4 cr. Total share holder fund is 10 cr. (This is good) First look it seem it is high price. Lets see how subscription takes place. It is very difficult to sail through because it is highly priced